Revenue from top 20 women health products in the U.S. 2016

There are many women’s health products available in the U.S. The top women’s health product based on revenue in 2016 was Prolia, marketed by Amgen. Prolia generated 1.05 billion U.S. dollars in revenue in 2016. Prolia is used for the treatment of osteoporosis. Comparatively, the second highest revenue generating health product for women was Premarin which generated 956 million U.S. dollars. Women’s health concerns Women face specific health issues including certain cancers, diseases, mental health challenges and reproductive health issues. A recent survey indicated that the most pressing health issues among American women include mental health, cancer and heart health. The leading causes of death among women in the United States are similar to these concerns. Heart disease and cancer are the top killers, followed by stroke. Women’s preventative health measures Female health and family planning are hugely important for women’s health. About half of U.S. women had visited a gynecologist within the past year. Gynecologists are responsible for many aspects of female health including child birth, pap smears and breast exams. The percentage of U.S. women that had received a pap test has decreased in recent years. One female health product that is on the rise is contraceptive. The sales of over-the-counter contraceptive products for women has increased in recent years. Contraceptives have become much more affordable in the United States as there are no longer patents that prevent a combined use of estrogen and progesterone for oral contraception. Both of these hormones are easy to synthesize and manufacture.

美国市场上女性健康产品种类繁多。以2016年营收为标准，Amgen公司旗下产品Prolia位居女性健康产品之首，当年创收达10.5亿美元。Prolia主要用于治疗骨质疏松症。与之相比，2016年营收位列第二的女性健康产品为Premarin，其营收为9.56亿美元。女性健康问题女性面临特定健康问题，包括某些癌症、疾病、心理健康挑战以及生殖健康问题。一项近期调查显示，美国女性最紧迫的健康问题包括心理健康、癌症和心脏健康。在美国，女性死亡的主要原因与这些关注点相似。心脏病和癌症是主要的杀手，其次是中风。女性的预防性健康措施女性健康和家庭规划对女性健康至关重要。大约一半的美国女性在过去一年内曾访问过妇科医生。妇科医生负责女性健康的多个方面，包括生育、宫颈涂片检查和乳腺检查。近年来，接受宫颈涂片检查的美国女性比例有所下降。一种女性健康产品正在兴起，那就是避孕药。近年来，女性非处方避孕药的销售量有所增加。在美国，避孕药的价格变得更加低廉，因为已不存在阻止雌激素和孕酮联合用于口服避孕的专利。这两种激素均易于合成和制造。